{
    "study_accession": "SDY690",
    "actual_completion_date": "2011-12-30",
    "actual_enrollment": 12,
    "actual_start_date": "2011-03-21",
    "age_unit": "Years",
    "brief_description": "This project will contribute to the overall vision and goals of this U19 by analyzing the role of adjuvants in the humoral response to hep B vaccination in healthy individuals.",
    "brief_title": "Systems Biology Study to Investigate Immune Correlates to Hepatitis B Vaccine Engerix-B comparing cellular responses and gene expression patterns between PBMCs (cell sorts) and whole blood samples (see companion studies SDY816 and SDY299)",
    "clinical_trial": "N",
    "condition_studied": "Vaccine responses in healthy adult population.",
    "dcl_id": 2,
    "description": "This project will contribute to the overall vision and goals of this U19 by analyzing the role of adjuvants in the humoral response to hep B vaccination in healthy individuals.",
    "doi": "10.21430/M3F8W7VA7O",
    "endpoints": "Patterns of cellular responses and gene activation induced by Engerix-B. Correlation of patterns of cellular and gene activation with anti-HBs antibody levels at various time points after injection.",
    "gender_included": "Female, Male",
    "hypothesis": "That identifying cellular and transcriptional responses that correlate with different antibody responses to a single vaccine antigen will provide insights into to immune system dysfunctions that accompany age and disease (HIV and end stage renal failure).",
    "initial_data_release_date": "2016-03-18",
    "initial_data_release_version": "DR18",
    "intervention_agent": "Engerix-B",
    "latest_data_release_date": "2018-07-06",
    "latest_data_release_version": "DR27",
    "maximum_age": "  69.00",
    "minimum_age": "  51.00",
    "objectives": "Document the changes in cellular responses and gene expression patterns in serial blood samples collected from healthy older adults after vaccination with Engerix-B. Determine which of these changes correlate with the development of protective levels of antibody (anti-HBsAg IgM 10 milli-International units per milliliter [mIU/mL]) to hepatitis B virus (HBV). Compare and contrast the cellular responses and gene expression patterns in healthy older adults after the first vs. second injection with Engerix-B.",
    "official_title": "Systems Biology Study to Investigate Immune Correlates to Hepatitis B Vaccine Engerix-B comparing cellular responses and gene expression patterns between PBMCs (cell sorts) and whole blood samples collected from healthy older adults (see companion studies SDY816 and SDY299)",
    "sponsoring_organization": "NIAID",
    "target_enrollment": null,
    "workspace_id": 2799,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM2974",
            "description": "Participants that received Engerix-B",
            "name": "Engerix-B Cohort 1_Cohort2"
        }
    ],
    "personnel": [
        {
            "first_name": "Robert",
            "last_name": "Coffman",
            "organization": "Dynavax Technologies Corporation",
            "role_in_study": "Principal Investigator",
            "site_name": "Dynavax Technologies Corporation"
        }
    ],
    "pubmed": [
        {
            "title": "Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine.",
            "journal": "Vaccine.",
            "month": "Mar",
            "year": "2012",
            "doi": "10.1016/j.vaccine.2012.02.001. Epub 2012 Feb 14.",
            "pubmed_id": "22342916"
        },
        {
            "title": "Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age.",
            "journal": "Vaccine.",
            "month": "Nov",
            "year": "2013",
            "doi": "10.1016/j.vaccine.2013.05.068. Epub 2013  May 30.",
            "pubmed_id": "23727002"
        },
        {
            "title": "Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18-70 years of age.",
            "journal": "Vaccine.",
            "month": "Jul",
            "year": "2015",
            "doi": "10.1016/j.vaccine.2015.05.070. Epub 2015 Jun 9.",
            "pubmed_id": "26067185"
        },
        {
            "title": "Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.",
            "journal": "Vaccine.",
            "month": "Jan",
            "year": "2018",
            "doi": "10.1016/j.vaccine.2017.12.038. Epub 2017 Dec 27.",
            "pubmed_id": "29289383"
        }
    ],
    "program": [
        {
            "program_name": "Human Immunology Project Consortium (HIPC) RFA-AI-14-007",
            "contract_name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans"
        }
    ],
    "assay": [
        {
            "measurement_technique": "Transcription profiling by array",
            "number_of_expsamples": 192
        }
    ],
    "subject": {
        "race": [
            {
                "race": "White",
                "count": 12
            }
        ],
        "gender": [
            {
                "Female": 6
            },
            {
                "Male": 6
            }
        ]
    }
}
